-
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
Post on 5/17/18
-
Pharmaceutical Industry Study Highlights the Evolving Role of Field-Based Medical Teams in Serving Managed Care Organizations
Post on 4/29/18
-
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
Post on 4/23/18
-
ASAP Urgent Dental Care Planning Expansion to Raleigh, Charlotte and Fayetteville, NC
Post on 4/20/18
-
Argos Therapeutics Stock Falls 68% as it Terminates Drug Trial
Post on 4/19/18
-
VTV Therapeutics Shares Plunge Following Failure of Alzheimer’s Clinical Trial
Post on 4/9/18
-
Aeterna Zentaris Files Management Information Circular
Post on 4/9/18
-
ReForm Biologics and KBI Biopharma Announce Strategic Partnership
Post on 4/4/18
-
Dova Fires Auditor KPMG, Hires Ernst & Young
Post on 3/28/18
-
Fennec Pharmaceuticals Receives Breakthrough Therapy Designation by FDA for PEDMARK
Post on 3/27/18
-
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
Post on 3/27/18
-
NovaQuest Capital Management Acquires CutisPharma
Post on 3/26/18
-
Fennec Pharmaceuticals Granted Fast Track Designation From FDA
Post on 3/25/18
-
BioDelivery’s Earnings Miss Expectations, But Revenue Beats Estimates
Post on 3/23/18
-
Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma
Post on 3/19/18
-
G1 Therapeutics Announces Closing of Offering of Common Stock
Post on 3/12/18
-
DeGen Medical Receives E3 MIS System FDA Clearance
Post on 3/11/18
-
G1 Therapeutics Announces Pricing of Offering of Common Stock
Post on 3/8/18
-
Durham-based Argos Therapeutics Has Enough Cash To Last Through End Of 2018
Post on 3/8/18
-
PRA Health Sciences Named Best CRO in Asia
Post on 3/6/18
-
G1 Therapeutics Announces Proposed Offering of Common Stock
Post on 3/5/18
-
Raleigh-based Innovate Bio Stock Rises 54%, Hopes Celiac Disease Drug Is The First Of Many
Post on 3/4/18
-
Tenax Therapeutics Announces Reverse Stock Split
Post on 2/25/18
-
Dova Pharmaceuticals Prices Offering of Common Stock
Post on 2/22/18
-
Dova Pharmaceuticals Announces Proposed Offering of Common Stock
Post on 2/20/18
Charlotte Raleigh
